Catatonia Associated with Another Mental Disorder (ICD-11: 6A40)

1. Introduction

Catatonia associated with another mental disorder represents a complex neuropsychiatric syndrome that frequently challenges mental health professionals in various clinical contexts. Characterized by marked psychomotor disturbances, this condition manifests through alterations in motor activity that can range from profound immobility to extreme agitation, always occurring in the context of a preexisting or concurrent mental disorder.

The clinical importance of this condition cannot be underestimated. Catatonia represents a medical emergency that, when not recognized and treated appropriately, can progress to serious complications, including dehydration, malnutrition, thromboembolism, rhabdomyolysis, and even neuroleptic malignant syndrome. Epidemiological studies indicate that catatonia occurs in approximately 10% of hospitalized psychiatric patients, being more common in mood disorders than traditionally recognized.

The recognition of catatonia as a transdiagnostic syndrome represents a significant advance in modern psychiatric understanding. Historically associated exclusively with schizophrenia, it is now understood that catatonia can manifest in various mental disorders, including bipolar disorders, major depression, psychotic disorders, neurodevelopmental disorders, and particularly in autism spectrum disorder.

Correct coding using the 6A40 code from ICD-11 is critical for multiple reasons: it ensures appropriate recognition of the condition in medical records, facilitates communication among professionals, allows for appropriate epidemiological tracking, ensures implementation of specific treatment protocols, and grounds decisions regarding resource allocation and therapeutic planning. Accurate documentation also has significant legal and administrative implications for continuity of care.

2. Correct ICD-11 Code

Code: 6A40

Description: Catatonia associated with another mental disorder

Parent category: Catatonia (without specific numerical subcategorization in the higher hierarchy)

Official definition: Catatonia associated with another mental disorder is a syndrome of essentially psychomotor disturbances, characterized by the co-occurrence of several symptoms of reduced, increased, or abnormal psychomotor activity, which occurs in the context of another mental disorder, such as schizophrenia or other primary psychotic disorders, mood disorders and neurodevelopmental disorders, especially autism spectrum disorder.

This specific ICD-11 code represents an important conceptual evolution in the classification of mental disorders. Unlike previous systems that fragmented catatonia into multiple diagnostic categories, code 6A40 recognizes the transdiagnostic nature of this syndrome, allowing its identification regardless of the underlying mental disorder.

The structure of ICD-11 requires that, when using code 6A40, the clinician also document the associated mental disorder through additional coding. This dual approach ensures that both the catatonic syndrome and the primary psychiatric condition are adequately recorded, providing a more complete understanding of the patient's clinical presentation.

It is fundamental to understand that code 6A40 does not replace the diagnosis of the underlying mental disorder, but complements it, signaling the presence of a significant complication that requires specific intervention and intensive monitoring.

3. When to Use This Code

The code 6A40 should be applied in specific clinical situations where catatonic syndrome is clearly associated with another diagnosed or diagnosable mental disorder. Below are detailed practical scenarios:

Scenario 1: Catatonia in Major Depressive Episode A patient with an established diagnosis of major depressive disorder presents to a psychiatric emergency unit with complete mutism, rigid posture, food refusal for 72 hours, and extreme negativism. Evaluation reveals catatonic stupor with catalepsy. In this case, code 6A40 is appropriate along with the specific code for the depressive episode, as catatonia clearly developed in the context of mood disorder.

Scenario 2: Catatonia in Schizophrenia A patient with schizophrenia under outpatient follow-up develops an acute episode of catatonic excitement, characterized by purposeless psychomotor agitation, complex stereotypies, prominent echolalia, and impulsivity. The presence of multiple catatonic signs (minimum of three symptoms) in the context of primary psychotic disorder justifies the use of code 6A40 as an additional diagnosis.

Scenario 3: Catatonia in Bipolar Disorder - Manic Episode During hospitalization for severe manic episode, a patient develops catatonic symptoms including bizarre mannerisms, abnormal posture maintained for hours, automatic obedience, and waxy flexibility. Appropriate documentation requires both the code for the manic episode and code 6A40 for the superimposed catatonic syndrome.

Scenario 4: Catatonia in Autism Spectrum Disorder An adolescent with previously diagnosed autism spectrum disorder presents with acute functional deterioration with development of immobility, progressive selective mutism, postural rigidity, and complete refusal of interaction. Evaluation confirms catatonic syndrome secondary to neurodevelopmental disorder, justifying the application of code 6A40.

Scenario 5: Catatonia in Schizoaffective Disorder A patient under treatment for bipolar-type schizoaffective disorder develops a mixed presentation with catatonic features, including alternation between stupor and agitation, negativism, partial mutism, and bizarre postures. The complexity of the presentation requires dual coding: schizoaffective disorder and associated catatonia (6A40).

Scenario 6: Catatonia in Brief Psychotic Disorder Following a significant stressor event, a patient with no prior psychiatric history develops acute psychotic presentation accompanied by prominent catatonic symptoms, including stupor, catalepsy, and negativism. Even in recently onset psychotic disorders, the presence of catatonia should be coded with 6A40.

For correct application of code 6A40, the following must be present: (1) at least three characteristic psychomotor symptoms of catatonia; (2) established diagnosis or investigation of mental disorder; (3) exclusion of general medical causes or substance-induced etiology as primary cause; (4) duration and intensity sufficient to cause significant functional impairment.

4. When NOT to Use This Code

Diagnostic specificity is essential to avoid inadequate coding. Code 6A40 should NOT be used in the following situations:

Substance or Medication-Induced Catatonia: When the catatonic syndrome is clearly resulting from use, intoxication or withdrawal of psychoactive substances, or adverse effects of medications (particularly antipsychotics), the appropriate code is 6A41, not 6A40. Examples include catatonia secondary to phencyclidine intoxication, neuroleptic malignant syndrome, or benzodiazepine withdrawal.

Catatonia Secondary to General Medical Conditions: When clinical evaluation identifies a medical condition as the primary cause of catatonic syndrome (autoimmune encephalitis, brain tumors, cerebrovascular accidents, hepatic encephalopathy, hypercalcemia, acute intermittent porphyria), the underlying medical condition should be coded primarily, and catatonia documented as a secondary manifestation, not using code 6A40.

Isolated Psychomotor Symptoms: The presence of individual psychomotor symptoms or only two catatonic symptoms does not meet criteria for complete catatonic syndrome. Isolated mannerisms in schizophrenia, psychomotor retardation in depression without other catatonic signs, or isolated psychomotor agitation do not justify the use of code 6A40.

Stereotypies in Neurodevelopmental Disorders without Complete Syndrome: Patients with autism spectrum disorder frequently present motor stereotypies as part of the usual clinical presentation. Only when there is acute deterioration with development of complete catatonic syndrome (multiple additional symptoms) should code 6A40 be applied.

Conversion or Dissociative Symptoms: Presentations of immobility or motor alterations in the context of dissociative or conversion disorders have specific codes and should not be classified as catatonia associated with mental disorder.

Malingering or Voluntary Behavior: When clinical evaluation suggests intentional behavior or malingering, without evidence of genuine neuropsychiatric syndrome, code 6A40 is inappropriate.

Appropriate differentiation requires comprehensive clinical evaluation, including detailed history, complete physical examination, laboratory investigation and neuroimaging when indicated, in addition to application of specific scales for catatonia.

5. Step-by-Step Coding Process

Step 1: Assess Diagnostic Criteria

Diagnostic confirmation of catatonia requires systematic evaluation using validated instruments. The Bush-Francis Catatonia Rating Scale (BFCRS) represents the most widely used instrument, assessing 23 catatonic signs. The screening version contains 14 items, with the presence of two or more signs suggesting catatonia, after which the full scale should be applied.

Cardinal symptoms include: stupor (marked decrease in responsiveness to the environment), catalepsy (passive induction of posture against gravity), waxy flexibility (mild resistance during repositioning), mutism (absence or extreme reduction of verbal response), negativism (opposition or absence of response to instructions), abnormal posture (spontaneous maintenance of postures against gravity), mannerisms (peculiar and circumstantial voluntary movements), stereotypies (repetitive purposeless movements), agitation not influenced by external stimuli, grimacing, echolalia (repetition of examiner's words), echopraxia (imitation of examiner's movements), and automatic obedience.

The evaluation should include the psychological pillow test (patient maintains head elevated after pillow removal), Mitgehen test (exaggerated movement of body part in response to light pressure), and observation of rigidity, impulsivity, and withdrawal.

Step 2: Verify Specifiers

Although code 6A40 does not have formal severity specifiers in the ICD-11 structure, clinical documentation should detail:

Severity: Mild (3-4 symptoms with moderate functional impairment), moderate (5-7 symptoms with significant impairment), severe (8 or more symptoms or presence of malignant catatonia with autonomic instability).

Duration: Acute (less than one month), subacute (1-3 months), chronic (more than three months).

Predominant features: Catatonic stupor (predominant hypoactivity), catatonic excitement (predominant hyperactivity), or mixed form.

Complications: Presence of dehydration, malnutrition, pressure ulcers, deep vein thrombosis, rhabdomyolysis, or progression to malignant catatonia.

Step 3: Differentiate from Other Codes

Differentiation from 6A41 (Catatonia Induced by Substance or Medication):

The fundamental distinction is based on etiology. Code 6A41 is used when there is clear temporal relationship between substance/medication exposure and development of catatonic symptoms, with evidence that the substance can produce catatonia. Examples include neuroleptic malignant syndrome (antipsychotics), catatonia from benzodiazepine withdrawal, or stimulant intoxication.

For 6A40, catatonia develops in the context of mental disorder, even if the patient is taking medications. Chronology is essential: if catatonic symptoms precede medication introduction or persist after discontinuation, 6A40 is more appropriate. When there is ambiguity (patient with schizophrenia on antipsychotic develops catatonia), clinical evaluation should consider doses, duration of exposure, and specific features to determine whether it is neuroleptic malignant syndrome (6A41) or catatonia associated with psychotic disorder (6A40).

Step 4: Required Documentation

Checklist of Mandatory Information:

[ ] Specific list of catatonic symptoms present (minimum three)
[ ] Duration of symptoms with onset date
[ ] Score on catatonia assessment scale (BFCRS or similar)
[ ] Diagnosis of associated mental disorder with corresponding ICD-11 code
[ ] Exclusion of general medical causes (laboratory results, neuroimaging)
[ ] Exclusion of substance-induced etiology (use history, chronology)
[ ] Level of functional impairment
[ ] Presence or absence of medical complications
[ ] Response to therapeutic trial with benzodiazepines (if performed)
[ ] Justification for use of code 6A40 specifically

Appropriate Documentation:

"Patient presents with catatonic syndrome characterized by [list specific symptoms] with duration of [time], score of [X] on Bush-Francis scale, in the context of [mental disorder - ICD-11 code]. Laboratory investigation and neuroimaging ruled out general medical causes. Chronology incompatible with medication-induced etiology. Coding: 6A40 (Catatonia associated with another mental disorder) + [code of underlying mental disorder]."

6. Complete Practical Example

Clinical Case:

A 28-year-old female patient with a history of bipolar I disorder diagnosed five years ago, in irregular outpatient follow-up. She presented to psychiatric emergency accompanied by family members who reported progressive deterioration over the past two weeks.

Initial Presentation:

Family members described that three weeks ago the patient began a depressive episode with depressed mood, anhedonia, social withdrawal, and insomnia. Over the past seven days, there was marked worsening with development of near-complete mutism, food refusal, remaining in fetal position in bed, and absence of response to verbal requests. Over the past 48 hours, she completely stopped eating and drinking, remaining immobile.

Evaluation Performed:

On physical examination, the patient was in fetal position, eyes open but without eye contact, without verbal response to questioning. Vital signs: BP 100/60 mmHg, HR 58 bpm, temperature 36.2°C. Neurological examination: isochoric pupils and photoreactive, without evident focal deficits.

Detailed psychiatric evaluation revealed:

Complete mutism: total absence of verbal response
Stupor: markedly diminished responsiveness to environment
Negativism: passive resistance to mobilization attempts
Catalepsy: right upper extremity maintained elevated position for three minutes after positioning by examiner
Abnormal posture: maintenance of fetal position even when repositioned
Withdrawal: absence of response to mild painful stimuli
Rigidity: increased resistance to passive mobilization

Bush-Francis Scale score (screening version): 10 points, indicating severe catatonia.

Complementary Investigation:

Laboratory tests: complete blood count normal, renal function preserved, electrolytes with mild hyponatremia (Na+ 132 mEq/L), normal liver function, normal thyroid function, serologies for HIV and syphilis negative, vitamin B12 and folic acid normal.

Cranial computed tomography: without acute changes.

Electroencephalogram: nonspecific diffuse slowing, without epileptiform activity.

Diagnostic Reasoning:

The patient presents with complete catatonic syndrome (seven symptoms identified) developed in the context of a depressive episode in a patient with established bipolar I disorder. The chronology indicates that catatonic symptoms emerged after the onset of the depressive episode, representing a complication of the mood disorder. Investigation ruled out general medical causes and there is no evidence of substance induction (patient was not using medications in recent weeks due to treatment abandonment).

Coding Justification:

The primary diagnosis is bipolar I disorder, current episode severe depression. The presence of complete catatonic syndrome, with multiple psychomotor symptoms and elevated score on specific scale, in the context of this mood disorder, fully justifies the application of code 6A40.

Step-by-Step Coding:

Criteria Analysis:

✓ Presence of three or more catatonic symptoms (seven identified)
✓ Diagnosed mental disorder (bipolar I disorder)
✓ Exclusion of general medical causes (negative investigation)
✓ Exclusion of substance induction (no medication use)
✓ Significant functional impairment (complete incapacity)

Codes Selected:

Primary Code: 6A40 - Catatonia associated with another mental disorder

Additional Code: [6A80.2](/en/code/6A80.2) - Bipolar I disorder, current episode severe depression

Complete Justification:

The catatonic syndrome is clearly associated with the depressive episode of bipolar disorder, not being secondary to general medical condition or substances. Code 6A40 adequately captures the nature of the psychomotor complication, while the bipolar disorder code identifies the underlying mental condition. Dual coding is essential for complete documentation and appropriate therapeutic planning.

Complementary Codes:

E86 - Volume depletion (dehydration secondary to fluid refusal)

Therapeutic Plan Based on Coding:

Psychiatric hospitalization, parenteral hydration, therapeutic trial with lorazepam, consideration of electroconvulsive therapy if no response to benzodiazepines, monitoring of medical complications, and stabilization of the underlying mood disorder.

7. Related Codes and Differentiation

Within the Same Category:

6A41: Catatonia Induced by Substances or Medications

When to use 6A41 vs. 6A40:

Code 6A41 is appropriate when there is clear evidence that a psychoactive substance, medication, or toxin is the primary etiological agent of the catatonic syndrome. Criteria include: (1) temporal relationship between substance exposure and symptom development; (2) substance known to cause catatonia; (3) symptoms not explained by preexisting mental disorder; (4) improvement with substance removal.

Main Difference:

The fundamental distinction lies in etiology. In 6A40, catatonia is a manifestation or complication of a primary mental disorder. In 6A41, the substance/medication is the direct causal factor. Complex situations may arise when a patient with a mental disorder is on medications: neuroleptic malignant syndrome in a patient with schizophrenia should be coded as 6A41, since the antipsychotic is the direct causal agent, even though an underlying mental disorder exists.

Practical Examples:

Patient develops catatonia after initiation of high-dose haloperidol, with fever and extreme muscle rigidity → 6A41 (neuroleptic malignant syndrome)
Patient with bipolar disorder develops catatonia during depressive episode, without recent medication changes → 6A40
Catatonia after phencyclidine intoxication in a substance user → 6A41
Catatonia in unmedicated patient with schizophrenia, during psychotic exacerbation → 6A40

Differential Diagnoses:

Neuroleptic Malignant Syndrome: Although classified under 6A41, it deserves special mention. It is characterized by extreme muscle rigidity, fever, autonomic instability, altered level of consciousness, and elevated creatine phosphokinase, related to antipsychotic use. It differs from catatonia associated with mental disorder by clear medication etiology and presence of prominent autonomic instability.

Selective Mutism: Childhood anxiety disorder characterized by consistent inability to speak in specific social situations. It differs by absence of other catatonic symptoms and selective pattern (child speaks normally at home but not at school).

Dissociative Stupor: Reduction or absence of voluntary movements and responsiveness in the context of dissociative disorder. It differs by absence of characteristic motor catatonic symptoms (catalepsy, waxy flexibility, stereotypies) and specific psychological context.

Locked-in Syndrome: Neurological condition with quadriplegia and anarthria but preserved consciousness, usually from pontine lesion. It differs by clear neurological etiology, preservation of vertical eye movements, and characteristic neuroimaging.

Drug-Induced Parkinsonism: May present with rigidity and bradykinesia, but without complete catatonic symptoms. It differs by absence of catalepsy, negativism, mannerisms, and other characteristic signs of catatonia.

8. Differences with ICD-10

Equivalent ICD-10 Code:

In ICD-10, catatonia did not have a unique transdiagnostic code. Depending on the context, the following were used:

F20.2 - Catatonic schizophrenia
F06.1 - Organic catatonic disorder
F32.3 or F33.3 - Severe depressive episode with psychotic symptoms (when it included catatonia)

Main Changes in ICD-11:

1. Transdiagnostic Recognition: ICD-11 establishes catatonia as an independent syndrome that can occur in multiple mental disorders, not limited to schizophrenia. This change reflects decades of evidence demonstrating that catatonia is more common in mood disorders than in schizophrenia.

2. Mandatory Dual Coding: While ICD-10 frequently incorporated catatonia within the primary diagnosis (catatonic schizophrenia), ICD-11 requires separate coding of the catatonic syndrome (6A40) and the associated mental disorder, providing more precise documentation.

3. Clear Differentiation of Causes: ICD-11 explicitly distinguishes catatonia associated with mental disorder (6A40) from substance-induced catatonia (6A41), whereas ICD-10 used less specific categories.

4. Elimination of Schizophrenic Subtypes: ICD-10 included catatonic schizophrenia as a specific subtype (F20.2). ICD-11 abandoned the classification by schizophrenia subtypes, recognizing that catatonic features can occur in any presentation of schizophrenia and should be coded additionally with 6A40.

Practical Impact of These Changes:

Improved Detection: The recognition of catatonia as a transdiagnostic entity increases clinical awareness to identify it in various contexts, not only in schizophrenia, potentially improving detection and treatment rates.

Epidemiological Accuracy: Separate coding allows more accurate tracking of catatonia prevalence in different mental disorders, facilitating research and service planning.

Treatment Protocols: Specific identification through code 6A40 signals the need for targeted interventions (benzodiazepines, electroconvulsive therapy), regardless of the underlying mental disorder.

Transition in Practice: Professionals familiar with ICD-10 must adapt to the new logic: instead of diagnosing "catatonic schizophrenia," they now diagnose "schizophrenia" + "catatonia associated with another mental disorder," using both corresponding codes.

9. Frequently Asked Questions

1. How is catatonia associated with another mental disorder diagnosed?

The diagnosis is based primarily on systematic clinical evaluation using validated instruments. The Bush-Francis Catatonia Rating Scale is the most widely accepted standard, assessing 23 catatonic signs. The presence of three or more catatonic symptoms constitutes the diagnostic criterion. The examination should be performed in a quiet environment, with careful observation of the patient's spontaneous behavior and specific tests (catalepsy, waxy flexibility, automatic obedience). In addition to psychiatric evaluation, medical investigation is essential to exclude organic causes, including laboratory tests (complete blood count, electrolytes, renal and hepatic function, thyroid function, serum calcium, vitamin B12), neuroimaging when indicated, and electroencephalogram in selected cases. Therapeutic testing with benzodiazepines (lorazepam test) has diagnostic and therapeutic value: significant improvement following intravenous lorazepam administration supports the diagnosis of catatonia.

2. Is treatment available in public health systems?

Treatment for catatonia is generally available in mental health services in various countries, although specific availability varies by region and local resources. Main interventions include benzodiazepines (particularly lorazepam), which are widely available in public health systems as relatively low-cost medications. Electroconvulsive therapy, a second-line or first-line treatment in severe cases, is available in specialized psychiatric centers in many public systems, although there may be waiting lists or limited availability in rural areas or those with restricted resources. Supportive treatment (hydration, nutrition, complication prevention) is universally available in general hospitals. The main barrier is generally not the availability of treatments, but adequate recognition of the syndrome, highlighting the importance of professional training.

3. How long does treatment last?

Treatment duration varies significantly depending on severity, underlying mental disorder, and therapeutic response. In the acute phase, when there is adequate response to benzodiazepines, significant improvement can occur within days to weeks. Typically, lorazepam is administered in divided doses (2-4 mg three times daily, potentially reaching up to 24 mg/day in severe cases) until symptom resolution. Electroconvulsive therapy, when indicated, generally requires 6-12 sessions over 2-4 weeks. After resolution of acute catatonic syndrome, focus shifts to treatment of the underlying mental disorder, which may require months to years of follow-up. Some patients develop recurrent catatonia, requiring prolonged maintenance treatment. Chronic forms may require continuous interventions. Regular follow-up is essential even after resolution, as recurrences are possible, especially if the underlying mental disorder is not adequately controlled.

4. Can this code be used in medical certificates?

Yes, code 6A40 can and should be used in official medical documentation, including certificates, when appropriate. Use in certificates should consider the context and purpose of the document. For work or academic leave, coding catatonia is pertinent as it documents an incapacitating condition requiring intensive treatment. Many professionals choose to include both code 6A40 and the code for the underlying mental disorder for complete documentation. In some jurisdictions, it may be appropriate to use additional descriptive terminology ("severe psychomotor syndrome") to facilitate understanding by non-specialists. Confidentiality issues should be considered: although coding is technically appropriate, the level of detail disclosed should respect patient preferences and local legal requirements. For administrative purposes (insurance, disability benefits), precise coding is generally necessary and beneficial to the patient.

5. Does catatonia always require hospitalization?

Most cases of catatonia, especially when associated with code 6A40, require hospitalization due to potential severity and risk of complications. Absolute indications for admission include: refusal of food or fluids with risk of dehydration/malnutrition, complete immobility, risk of thromboembolism, autonomic instability, concomitant severe psychotic symptoms, risk of self-harm or suicide, and need for electroconvulsive therapy. Very mild cases, with partial preservation of functionality, ability to eat and drink, robust family support, and possibility of frequent monitoring, may occasionally be managed on an outpatient basis with intensive supervision. However, this is the exception, not the rule. Hospitalization allows continuous monitoring, safe administration of treatments, prevention of medical complications, and management of the underlying mental disorder in a controlled environment. Duration of hospitalization varies from days (mild cases with rapid response) to weeks or months (severe or refractory cases).

6. Are patients with catatonia aware of what is happening?

This question is complex and the answer varies depending on the type and severity of catatonia. In catatonic stupor, although the patient appears disconnected and unresponsive, studies using retrospective reports after recovery indicate that many patients maintain some level of consciousness and environmental perception, even when completely unable to respond. Patients frequently report having heard conversations and perceived events around them during the catatonic episode. In catatonic excitement, there is generally a greater level of activity, but with qualitative alteration of consciousness. The presence of concomitant psychotic symptoms (delusions, hallucinations) can significantly alter subjective experience. This possibility of preserved consciousness has important ethical implications: professionals should communicate respectfully with catatonic patients, explain procedures, and maintain dignity, even when there appears to be no response. Family members should be informed of this possibility, encouraging positive communication and comforting presence.

7. Can catatonia leave permanent sequelae?

Most patients with adequately and early treated catatonia recover completely without permanent sequelae. However, complications can result in persistent damage. Prolonged immobility can cause muscle contractures, atrophy, deep pressure ulcers, and thromboembolism with sequelae (pulmonary embolism, stroke). Severe malnutrition and dehydration can result in organic damage. Severe rhabdomyolysis can cause renal failure. Untreated malignant catatonia with autonomic instability has significant mortality. Beyond physical complications, catatonic episodes can impact psychosocial functioning, with prolonged periods away from work, academic, and social activities. Prognosis fundamentally depends on: early recognition, adequate treatment, control of the underlying mental disorder, and prevention of medical complications. Patients with recurrent episodes may develop progressive functional deterioration if the underlying mental disorder is not optimally controlled.

8. Are there factors that increase the risk of developing catatonia?

Various risk factors have been identified. Specific mental disorders confer greater risk: bipolar disorder (particularly severe depressive episodes), psychotic disorders (schizophrenia, schizoaffective disorder), autism spectrum disorder, and neurodevelopmental disorders. Previous history of catatonia significantly increases the risk of recurrence. Neurobiological factors include neurotransmitter dysfunction (particularly GABA and glutamate), brain structural abnormalities, and genetic predisposition (family history of catatonia or severe mental disorders). Precipitating factors include abrupt discontinuation of benzodiazepines or lithium, introduction or increase of antipsychotics (especially typical ones), significant psychosocial stressors, and intercurrent medical conditions (infections, metabolic disturbances). Understanding these factors allows identification of higher-risk patients and potentially implementation of preventive strategies, such as avoiding abrupt medication discontinuation, careful monitoring during therapeutic changes, and early intervention at the first sign of catatonic symptoms.

Conclusion:

Code 6A40 of ICD-11 represents a significant advance in the recognition and documentation of catatonia as a transdiagnostic syndrome that complicates various mental disorders. Adequate understanding of this code, its application criteria, and its differentiation from related conditions is essential for all mental health professionals. Precise coding not only ensures appropriate documentation but grounds critical therapeutic decisions, facilitates communication between professionals, and potentially saves lives through early recognition and adequate treatment of this severe but treatable syndrome. The detailed knowledge presented in this article empowers professionals to identify, document, and correctly code catatonia associated with mental disorders, contributing to better clinical outcomes and advancement of evidence-based psychiatric practice.

External References

This article was prepared based on reliable scientific sources:

References verified on 2026-02-03

Catatonia Associated with Another Mental Disorder

Compartilhar